Spiramycin III

Spiramycin III (SPMIII) is a main component of Spiramycin. Spiramycin (HY-100593) is a macrolide antibiotic produced by Streptomyces ambofaciens with against bacteria and Toxoplasma gondii activities, and also has antiparasitic effect[1][2].

Product Specifications

CAS Number

[24916-52-7]

UNSPSC

12352005

Target

Antibiotic; Bacterial; Parasite

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/spiramycin-iii.html

Smiles

C[C@@H]1[C@H](CC[C@@H](O1)O[C@@H]2[C@@H](C[C@@H]([C@@H]([C@@H](OC)[C@@H](CC(O[C@H](C)C/C=C\C=C\2)=O)OC(CC)=O)O[C@@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)N(C)C)O[C@@H]4O[C@H]([C@@H]([C@@](C)(C4)O)O)C)C)CC=O)C)N(C)C

Molecular Formula

C46H78N2O15

Molecular Weight

899.12

References & Citations

[1]X R Xu, et al. [Determination of partition coefficient by high-pressure liquid chromatography. I. Determination of partition coefficient of cinnamic acids and related compounds by reversed-phase high-pressure liquid chromatography (author's transl) ]. Yao Xue Xue Bao. 1979;14 (4) :246-52. |[2]Nguyen HC, et al. Post-PKS tailoring steps of the spiramycin macrolactone ring in Streptomyces ambofaciens. Antimicrob Agents Chemother. 2013 Aug;57 (8) :3836-42.